These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30361919)

  • 1. Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy.
    Charlson J
    Curr Treat Options Oncol; 2018 Oct; 19(12):65. PubMed ID: 30361919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.
    Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
    BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
    Schuetze SM; Patel S
    Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
    Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
    BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
    Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.
    Grobmyer SR; Maki RG; Demetri GD; Mazumdar M; Riedel E; Brennan MF; Singer S
    Ann Oncol; 2004 Nov; 15(11):1667-72. PubMed ID: 15520069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
    Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
    Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas.
    Scurr M; Judson I
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):489-500, vi. PubMed ID: 15939193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
    Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
    Wang B; Yu X; Xu S; Xu M
    Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
    Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
    BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
    Spunt SL; Francotte N; De Salvo GL; Chi YY; Zanetti I; Hayes-Jordan A; Kao SC; Orbach D; Brennan B; Weiss AR; van Noesel MM; Million L; Alaggio R; Parham DM; Kelsey A; Randall RL; McCarville MB; Bisogno G; Hawkins DS; Ferrari A
    Eur J Cancer; 2019 May; 112():98-106. PubMed ID: 30954717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant chemotherapy of soft tissue sarcoma].
    Lévy E; Thirion P; Piedbois P
    Cancer Radiother; 1997; 1(5):462-6. PubMed ID: 9587378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for using adjuvant chemotherapy as standard treatment of soft tissue sarcoma.
    Benjamin RS
    Semin Radiat Oncol; 1999 Oct; 9(4):349-51. PubMed ID: 10516381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.
    Pervaiz N; Colterjohn N; Farrokhyar F; Tozer R; Figueredo A; Ghert M
    Cancer; 2008 Aug; 113(3):573-81. PubMed ID: 18521899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
    Gortzak E; Azzarelli A; Buesa J; Bramwell VH; van Coevorden F; van Geel AN; Ezzat A; Santoro A; Oosterhuis JW; van Glabbeke M; Kirkpatrick A; Verweij J;
    Eur J Cancer; 2001 Jun; 37(9):1096-103. PubMed ID: 11378339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
    Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
    Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
    Tanaka K; Ozaki T
    Jpn J Clin Oncol; 2021 Feb; 51(2):180-184. PubMed ID: 33313851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?
    Hindi N; Martin-Broto J
    Curr Opin Oncol; 2021 Jul; 33(4):329-335. PubMed ID: 33973551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.